Related Experiment Video
Updated: Nov 3, 2025
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.1K
Improved Glycemic Control With a Digital Health Intervention in Adults With Type 2 Diabetes: Retrospective Study
Gretchen Zimmermann1, Aarathi Venkatesan1, Kelly Rawlings1
1Vida Health, San Francisco, CA, United States.
JMIR Diabetes
|June 2, 2021
Summary
Digital diabetes management significantly improved glycemic control, reducing hemoglobin A1c (HbA1c). Higher engagement with the program led to greater HbA1c reductions, showing its effectiveness for type 2 diabetes management.
Area of Science:
- Digital Health
- Endocrinology
- Public Health
Background:
- Traditional lifestyle interventions show limited success in managing type 2 diabetes.
- Digital interventions offer continuous support and personalized content for improved self-management.
- Digital health solutions may enhance glycemic control in diabetes care.
Purpose of the Study:
- To evaluate the effectiveness of a digital diabetes management program.
- To assess changes in glycemic control (HbA1c) in participants with type 2 diabetes.
- To explore the impact of program usage on diabetes outcomes.
Main Methods:
- Retrospective, single-arm study of 950 participants with type 2 diabetes.
- Intervention included remote provider sessions and structured diabetes management lessons.
- Hemoglobin A1c (HbA1c) was measured at baseline and follow-up (≥90 days).
Main Results:
- A significant HbA1c reduction of -0.81 points was observed (mean baseline 8.68 to follow-up 7.88).
- High-risk participants (HbA1c ≥8) showed an average reduction of -1.44 points.
- Higher program usage correlated with greater HbA1c decrease (P<.001).
Conclusions:
- Digital diabetes management interventions lead to clinically meaningful glycemic control improvements.
- Increased program engagement is associated with enhanced HbA1c reduction.
- Digital health offers a scalable and effective approach for diabetes management.
Keywords:
HbA1capp-baseddiabetesdiabetes interventiondigital healthglycemic improvementshealth coachingmHealthmobile healthtype 2 diabetesMore Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
477
04:24A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
12.0K
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
3.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.6K
01:15Diabetes: Management and Pharmacotherapy
656
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
656
01:15Diabetes: Symptoms, Diagnosis, and Complications
1.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.4K
01:22Diabetes Mellitus: Overview and Type I Subtype
4.1K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.1K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
380
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
380
01:23Dipeptidyl Peptidase 4 Inhibitors
315
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
315